Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matteo Ferro

Showing results (111-120 of 420) with videos related to

Pageof 42
Sort By:
International Journal of Molecular Sciences|April 27, 2024
Ischemia-Reperfusion Injury in Kidney Transplantation: Mechanisms and Potential Therapeutic TargetsFrancesco Lasorsa, Monica Rutigliano, Martina Milella, et al.
Central European Journal of Urology|August 2, 2021
The combination of waterjet ablation (Aquabeam<sup>®</sup>) and holmium laser power for treatment of symptomatic benign prostatic hyperplasia: early functional resultsDaniele D'Agostino, Michele Colicchia, Paolo Corsi, et al.
Urologic Oncology|January 11, 2015
Prognostic accuracy of Prostate Health Index and urinary Prostate Cancer Antigen 3 in predicting pathologic features after radical prostatectomyFrancesco Cantiello, Giorgio Ivan Russo, Matteo Ferro, et al.
Andrologia|May 1, 2020
Insertion of a testicular prosthesis at the time of radical orchiectomy for testicular cancer is safe in patients who will subsequently undergo chemotherapy or radiotherapyGennaro Musi, Gabriele Cozzi, Francesco Alessandro Mistretta, et al.
Urologic Oncology|September 13, 2011
Combined magnetic resonance spectroscopy and dynamic contrast-enhanced imaging for prostate cancer detectionSisto Perdonà, Giuseppe Di Lorenzo, Riccardo Autorino, et al.
Anti-Cancer Drugs|October 10, 2012
Peg-filgrastim and cabazitaxel in prostate cancer patientsGiuseppe Di Lorenzo, Carmine DʼAniello, Carlo Buonerba, et al.
Nature Communications|October 24, 2024
Socio-demographic and genetic risk factors for drug adherence and persistence across 5 common medication classesMattia Cordioli, Andrea Corbetta, Hanna Maria Kariis, et al.
International Journal of Molecular Sciences|February 15, 2020
Beyond PSA: The Role of Prostate Health Index (phi)Matteo Ferro, Ottavio De Cobelli, Giuseppe Lucarelli, et al.
Future Science OA|April 5, 2021
Urologic malignancies: advances in the analysis and interpretation of clinical findingsFelice Crocetto, Carlo Buonerba, Vincenzo Caputo, et al.
Medicine|December 26, 2015
Third-Line Chemotherapy for Metastatic Urothelial Cancer: A Retrospective Observational StudyGiuseppe Di Lorenzo, Carlo Buonerba, Teresa Bellelli, et al.
Pageof 42

Showing results (111-120 of 420) with videos related to

Sort By:
Pageof 42
International Journal of Molecular Sciences|April 27, 2024
Ischemia-Reperfusion Injury in Kidney Transplantation: Mechanisms and Potential Therapeutic TargetsFrancesco Lasorsa, Monica Rutigliano, Martina Milella, et al.
Central European Journal of Urology|August 2, 2021
The combination of waterjet ablation (Aquabeam<sup>®</sup>) and holmium laser power for treatment of symptomatic benign prostatic hyperplasia: early functional resultsDaniele D'Agostino, Michele Colicchia, Paolo Corsi, et al.
Urologic Oncology|January 11, 2015
Prognostic accuracy of Prostate Health Index and urinary Prostate Cancer Antigen 3 in predicting pathologic features after radical prostatectomyFrancesco Cantiello, Giorgio Ivan Russo, Matteo Ferro, et al.
Andrologia|May 1, 2020
Insertion of a testicular prosthesis at the time of radical orchiectomy for testicular cancer is safe in patients who will subsequently undergo chemotherapy or radiotherapyGennaro Musi, Gabriele Cozzi, Francesco Alessandro Mistretta, et al.
Urologic Oncology|September 13, 2011
Combined magnetic resonance spectroscopy and dynamic contrast-enhanced imaging for prostate cancer detectionSisto Perdonà, Giuseppe Di Lorenzo, Riccardo Autorino, et al.
Anti-Cancer Drugs|October 10, 2012
Peg-filgrastim and cabazitaxel in prostate cancer patientsGiuseppe Di Lorenzo, Carmine DʼAniello, Carlo Buonerba, et al.
Nature Communications|October 24, 2024
Socio-demographic and genetic risk factors for drug adherence and persistence across 5 common medication classesMattia Cordioli, Andrea Corbetta, Hanna Maria Kariis, et al.
International Journal of Molecular Sciences|February 15, 2020
Beyond PSA: The Role of Prostate Health Index (phi)Matteo Ferro, Ottavio De Cobelli, Giuseppe Lucarelli, et al.
Future Science OA|April 5, 2021
Urologic malignancies: advances in the analysis and interpretation of clinical findingsFelice Crocetto, Carlo Buonerba, Vincenzo Caputo, et al.
Medicine|December 26, 2015
Third-Line Chemotherapy for Metastatic Urothelial Cancer: A Retrospective Observational StudyGiuseppe Di Lorenzo, Carlo Buonerba, Teresa Bellelli, et al.
Pageof 42